Definitive Healthcare Expands Database Coverage With Detailed Research On Over 400+ Health Insurance Payors

Definitive Healthcare (http://www.definitivehc.com) has expanded its scope of market intelligence to include detailed and up-to-date information on over 400 payors. This significant addition to the Definitive Healthcare Suite will provide clients enhanced analytic capabilities for understanding key relationships between payors and providers as well as the market changes taking place due to ACO and HIE participation.

Clients will have access to payor executive contact information, technologies implemented, and payor affiliations such as ACOs and clinically integrated networks. John Macek, Vice President of Product Development at Definitive Healthcare, believes that “tracking payors will help our clients enhance their understanding of the entire healthcare market and the increasingly complex relationships between payors, providers and participants. As the market changes, we continue to innovate to help our clients adjust to these changes as quickly and effectively as possible.” With its proven record in data quality, client service, and innovative thinking, the payor database will help Definitive continue to be at the forefront of healthcare research.

Definitive Healthcare, LLC, headquartered in Framingham, MA, provides the most comprehensive and up-to-date information and insight across the entire healthcare continuum of care. The Definitive Healthcare database provides clients with powerful analytical tools useful for efficiently tracking hospitals, health systems, physician groups, accountable care organizations and payors.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.